A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
MK-8294, the study medicine, is a type of targeted therapy designed to treat certain solid tumors. The main goals of this study are to learn about the safety of MK-8294 and if people can tolerate it and find the highest dose level of MK-8294 that people can tolerate.
Has histologically or cytologically confirmed advanced/metastatic solid tumor; i... [+3]
HIV-infected participants with a history of Kaposi's sarcoma and/or Multicentric... [+9]